These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32829008)

  • 1. A signal peptide derived from Hsp60 induces protective cytotoxic T lymphocyte immunity against lymphoid malignancies independently of TAP and classical MHC-I.
    Chen XR; Yuan HH; Guo JH; Zhang WY; Li QQ; Huang GD; Zhang YJ; Jiang B; Liu F
    Cancer Lett; 2020 Dec; 494():47-57. PubMed ID: 32829008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PFA-fixed Hsp60sp-loaded dendritic cells as a vaccine for the control of mouse experimental allergic encephalomyelitis.
    Liu F; Zheng H; Qi Y; Wang X; Yang J; Han M; Zhang H; Jiang H
    Cell Mol Immunol; 2014 Mar; 11(2):169-74. PubMed ID: 24374852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation.
    Chen W; Zhang L; Liang B; Saenger Y; Li J; Chess L; Jiang H
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20472-7. PubMed ID: 18077361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.
    Jiang H; Canfield SM; Gallagher MP; Jiang HH; Jiang Y; Zheng Z; Chess L
    J Clin Invest; 2010 Oct; 120(10):3641-50. PubMed ID: 20877010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology.
    Zügel U; Schoel B; Yamamoto S; Hengel H; Morein B; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):451-8. PubMed ID: 7875208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm.
    Davies A; Kalb S; Liang B; Aldrich CJ; Lemonnier FA; Jiang H; Cotter R; Soloski MJ
    J Immunol; 2003 May; 170(10):5027-33. PubMed ID: 12734347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
    Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T
    Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
    Kemp RA; Ronchese F
    J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.
    Leavenworth JW; Tang X; Kim HJ; Wang X; Cantor H
    J Clin Invest; 2013 Mar; 123(3):1382-9. PubMed ID: 23376792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
    Marijt KA; Griffioen L; Blijleven L; van der Burg SH; van Hall T
    Cancer Immunol Immunother; 2022 Feb; 71(2):289-300. PubMed ID: 34142235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
    Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qa-1
    Zhang X; Sabio E; Krishna C; Ma X; Wang J; Jiang H; Havel JJ; Chan TA
    Mol Cancer Res; 2021 Jun; 19(6):1076-1084. PubMed ID: 33674442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.